Jin Lin
Papers
1
Total Citations
13
H-Index
1
About
Jin Lin is a leading cardiovascular surgeon whose research focuses on advancing minimally invasive and hybrid approaches to coronary revascularization. His major contributions center on comparing the efficacy and safety of minimally invasive direct coronary artery bypass grafting (MIDCAB), robotic-assisted coronary artery bypass grafting (RCABG), and hybrid coronary revascularization (HCR) for patients with multivessel coronary disease. In his highly cited 2019 systematic review and meta-analysis, Lin synthesized evidence to determine which strategy yields optimal outcomes, providing crucial guidance for surgical decision-making. This work has garnered 13 citations, reflecting its impact on clinical practice and ongoing debates in the field. Lin’s research is notable for its rigorous methodology and direct relevance to improving patient recovery and long-term results. By clarifying the trade-offs between less invasive techniques and traditional bypass surgery, he has helped shape contemporary revascularization strategies. His contributions are particularly valuable for surgeons and cardiologists seeking evidence-based approaches to complex coronary artery disease, and his work continues to influence the evolution of cardiac surgery toward more patient-centered, less invasive treatments.
Research Focus
Key Achievements
Top Papers
- 1